Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma Journal Article


Authors: Feigin, M. E.; Garvin, T.; Bailey, P.; Waddell, N.; Chang, D. K.; Kelley, D. R.; Shuai, S.; Gallinger, S.; McPherson, J. D.; Grimmond, S. M.; Khurana, E.; Stein, L. D.; Biankin, A. V.; Schatz, M. C.; Tuveson, D. A.
Article Title: Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma
Abstract: The contributions of coding mutations to tumorigenesis are relatively well known; however, little is known about somatic alterations in noncoding DNA. Here we describe GECCO (Genomic Enrichment Computational Clustering Operation) to analyze somatic noncoding alterations in 308 pancreatic ductal adenocarcinomas (PDAs) and identify commonly mutated regulatory regions. We find recurrent noncoding mutations to be enriched in PDA pathways, including axon guidance and cell adhesion, and newly identified processes, including transcription and homeobox genes. We identified mutations in protein binding sites correlating with differential expression of proximal genes and experimentally validated effects of mutations on expression. We developed an expression modulation score that quantifies the strength of gene regulation imposed by each class of regulatory elements, and found the strongest elements were most frequently mutated, suggesting a selective advantage. Our detailed single-cancer analysis of noncoding alterations identifies regulatory mutations as candidates for diagnostic and prognostic markers, and suggests new mechanisms for tumor evolution. © 2017 Nature America, Inc., part of Springer Nature. All rights reserved.
Journal Title: Nature Genetics
Volume: 49
Issue: 6
ISSN: 1061-4036
Publisher: Nature Publishing Group  
Date Published: 2017-06-01
Start Page: 825
End Page: 833
Language: English
DOI: 10.1038/ng.3861
PROVIDER: scopus
PUBMED: 28481342
PMCID: PMC5659388
DOI/URL:
Notes: Article -- Export Date: 3 July 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors